VPix Medical Co., Ltd. , a company located in Seoul Biohub, announced on the 4th that it signed a business agreement (MOU) for clinical research and joint development using digital biopsy technology with Samsung Seoul Hospital and Korea University Anam Hospital .
Through this agreement, the two hospitals plan to cooperate in various fields such as clinical application of digital biopsy technology, development of precision diagnosis support models, operation of medical staff education programs, joint research, and academic presentations. The two hospitals will cooperate centered on the operation of the Center of Excellence (COE), and V-Pix Medical Co., Ltd. will focus on establishing a clinical cooperation system.
VPix Medical Co., Ltd. is providing a digital biopsy solution that supports real-time pathological diagnosis by developing the ultra-small confocal fluorescence microscope technology 'cCeLL'. This technology can secure fluorescence images of tissues in real time without the slide production process, and is used to assist in pathological diagnosis during surgery and for remote consultation (telepathology).
Currently, a multi-institutional clinical trial is underway for the class 2 medical device 'cCeLL – In vivo' that can come into contact with the body, and it is expected that this agreement will serve as an opportunity to strengthen the cooperative system with each institution and accelerate the creation of clinical applicability and research results.
In addition, we are also pursuing cooperation with Seoul National University Hospital and Seoul Metropolitan City Boramae Hospital, and plan to continuously expand clinical partnerships in the future. Recently, we were selected for the 'Global Expansion Growth Acceleration Program' hosted by Seoul Biohub, and are receiving various support such as US investor meetings and market entry strategy consulting, and are also making full-fledged advances into the US market.
“Digital biopsy technology is not just a simple imaging device, but a platform that supports medical professionals’ clinical judgment in real time,” said Hwang Kyung-min, CEO of VPix Medical. “We will develop it into a patient-centered technology through collaboration with various clinical institutions.”
- See more related articles
You must be logged in to post a comment.